IREB2
Iron-responsive element-binding protein 2
Also known as: IREB2_HUMAN, IRP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48200
- Gene
- IREB2
- Ensembl
- ENSG00000136381
- Chromosome
- 15
- Canonical length
- 963 aa
- Protein class
- Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cell Junctions,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is an RNA-binding protein that acts to regulate iron levels in the cells by regulating the translation and stability of mRNAs that affect iron homeostasis under conditions when iron is depleted. When iron levels are low, this protein binds to iron-responsive elements (IRES), stem-loop structures located either in the 5' or 3' UTRs. Binding to the 5' UTR represses translation, while binding to the 3' UTR inhibits mRNA degradation. When iron is found in the cell, this protein is degraded in a F-box and leucine rich repeat protein 5-dependent manner. Variants in this gene have been associated with lung cancer and chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
963 residues, UniProt reviewed canonical sequence.
>P48200|IREB2
1 MDAPKAGYAF EYLIETLNDS SHKKFFDVSK LGTKYDVLPY SIRVLLEAAV RNCDGFLMKK
61 EDVMNILDWK TKQSNVEVPF FPARVLLQDF TGIPAMVDFA AMREAVKTLG GDPEKVHPAC
121 PTDLTVDHSL QIDFSKCAIQ NAPNPGGGDL QKAGKLSPLK VQPKKLPCRG QTTCRGSCDS
181 GELGRNSGTF SSQIENTPIL CPFHLQPVPE PETVLKNQEV EFGRNRERLQ FFKWSSRVFK
241 NVAVIPPGTG MAHQINLEYL SRVVFEEKDL LFPDSVVGTD SHITMVNGLG ILGWGVGGIE
301 TEAVMLGLPV SLTLPEVVGC ELTGSSNPFV TSIDVVLGIT KHLRQVGVAG KFVEFFGSGV
361 SQLSIVDRTT IANMCPEYGA ILSFFPVDNV TLKHLEHTGF SKAKLESMET YLKAVKLFRN
421 DQNSSGEPEY SQVIQINLNS IVPSVSGPKR PQDRVAVTDM KSDFQACLNE KVGFKGFQIA
481 AEKQKDIVSI HYEGSEYKLS HGSVVIAAVI SCTNNCNPSV MLAAGLLAKK AVEAGLRVKP
541 YIRTSLSPGS GMVTHYLSSS GVLPYLSKLG FEIVGYGCSI CVGNTAPLSD AVLNAVKQGD
601 LVTCGILSGN KNFEGRLCDC VRANYLASPP LVVAYAIAGT VNIDFQTEPL GTDPTGKNIY
661 LHDIWPSREE VHRVEEEHVI LSMFKALKDK IEMGNKRWNS LEAPDSVLFP WDLKSTYIRC
721 PSFFDKLTKE PIALQAIENA HVLLYLGDSV TTDHISPAGS IARNSAAAKY LTNRGLTPRE
781 FNSYGARRGN DAVMTRGTFA NIKLFNKFIG KPAPKTIHFP SGQTLDVFEA AELYQKEGIP
841 LIILAGKKYG SGNSRDWAAK GPYLLGVKAV LAESYEKIHK DHLIGIGIAP LQFLPGENAD
901 SLGLSGRETF SLTFPEELSP GITLNIQTST GKVFSVIASF EDDVEITLYK HGGLLNFVAR
961 KFSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IREB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- thymus: 28 nTPM
- thyroid gland: 27 nTPM
- bone marrow: 26 nTPM
- adrenal gland: 24 nTPM
- spleen: 23 nTPM
- tongue: 22 nTPM
Single-cell type
- adrenal cortex cells: 267 nCPM
- sertoli cells: 152 nCPM
- microglia: 121 nCPM
- tuft cells: 115 nCPM
- myonuclei: 114 nCPM
- neutrophil progenitors: 111 nCPM
Immune cell
- plasmacytoid DC: 4 nTPM
- basophil: 3.6 nTPM
- myeloid DC: 3.5 nTPM
- naive CD8 T-cell: 3.5 nTPM
- intermediate monocyte: 3.3 nTPM
- MAIT T-cell: 3 nTPM
Brain region
- cerebellum: 47 nTPM
- hypothalamus: 35 nTPM
- choroid plexus: 31 nTPM
- white matter: 30 nTPM
- cerebral cortex: 30 nTPM
- thalamus: 29 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IREB2.
Disease | AllUniProt
Conditions IREB2 is implicated in, by any mechanism.
- Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia (NDCAMA) MIM:618451
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 300 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOSIS AND MICROCYTIC ANEMIA
- Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.03
- DepMap mean gene effect
- -0.3
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- erythrocyte homeostasis
- intestinal absorption
- intracellular iron ion homeostasis
- mRNA stabilization
- multicellular organismal-level iron ion homeostasis
- osteoclast differentiation
- post-embryonic development
- protoporphyrinogen IX biosynthetic process
Molecular functions
- 4 iron, 4 sulfur cluster binding
- aconitate hydratase activity
- iron-responsive element binding
- metal ion binding
- mRNA regulatory element binding translation repressor activity
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aconitase A/isopropylmalate dehydratase small subunit, swivel domain
- Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha domain
- Aconitase/Iron-responsive element-binding protein 2
- Aconitase/3-isopropylmalate dehydratase, swivel
- Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 1/3
- Aconitase family, 4Fe-4S cluster binding site
- Aconitase, iron-sulfur domain
- Aconitase A, swivel domain
- Aconitase family (aconitate hydratase)
- Aconitase C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IREB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IREB2 as an antibody target. Whether an autoantibody or antibody against IREB2 could matter depends on whether native IREB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IREB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IREB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...